Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H T Greinix

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|January 23, 1999
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignanciesW Rabitsch, E Reiter, F Keil, et al.
Transplantation|November 15, 1995
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxisP Kalhs, S Brugger, I Schwarzinger, et al.
Blood|May 1, 1997
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasiaF Keil, O A Haas, G Fritsch, et al.
Bone Marrow Transplantation|March 2, 2010
Unrelated hematopoietic stem cell donors as research subjectsR J King, D L Confer, H T Greinix, et al.
Bone Marrow Transplantation|January 27, 2009
KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantationK Ludajic, Y Balavarca, H Bickeböller, et al.
Bone Marrow Transplantation|November 9, 2004
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donorsH T Greinix, I Faé, B Schneider, et al.
Annals of Hematology|January 6, 1999
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemiaE Reiter, H T Greinix, G Mitterbauer, et al.
Leukemia & Lymphoma|November 8, 2001
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisionsK Laczika, G Mitterbauer, M Mitterbauer, et al.
Transplantation|June 13, 1998
Subdural hygromas after bone marrow transplantation: results of a prospective studyT Staudinger, K Heimberger, W Rabitsch, et al.
British Journal of Haematology|September 1, 1999
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reactionG Mitterbauer, P Nemeth, S Wacha, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|January 23, 1999
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignanciesW Rabitsch, E Reiter, F Keil, et al.
Transplantation|November 15, 1995
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxisP Kalhs, S Brugger, I Schwarzinger, et al.
Blood|May 1, 1997
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasiaF Keil, O A Haas, G Fritsch, et al.
Bone Marrow Transplantation|March 2, 2010
Unrelated hematopoietic stem cell donors as research subjectsR J King, D L Confer, H T Greinix, et al.
Bone Marrow Transplantation|January 27, 2009
KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantationK Ludajic, Y Balavarca, H Bickeböller, et al.
Bone Marrow Transplantation|November 9, 2004
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donorsH T Greinix, I Faé, B Schneider, et al.
Annals of Hematology|January 6, 1999
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemiaE Reiter, H T Greinix, G Mitterbauer, et al.
Leukemia & Lymphoma|November 8, 2001
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisionsK Laczika, G Mitterbauer, M Mitterbauer, et al.
Transplantation|June 13, 1998
Subdural hygromas after bone marrow transplantation: results of a prospective studyT Staudinger, K Heimberger, W Rabitsch, et al.
British Journal of Haematology|September 1, 1999
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reactionG Mitterbauer, P Nemeth, S Wacha, et al.
Pageof 8